merpublic's brca2 [43 articles] Export Sort

Recent papers added to merpublic's library classified by the tag brca2. You can also see everyone's brca2.

Hide details

	Weighing Options for Cancer Risk Reduction in Carriers of BRCA1 and BRCA2 Mutations [My Copy] In J Clin Oncol (7 December 2009), JCO.2009.25.6875. by Zsofia K. Stadler, Noah D. Kauff posted to risk brca2 brca1 by merpublic on 2009-12-08 03:22:37 as
	Efficiency of BRCAPRO and Myriad II mutation probability thresholds versus cancer history criteria alone for BRCA1/2 mutation detection [My Copy] Familial Cancer In Familial Cancer (1 December 2009) by J. van Harssel, C. van Roozendaal, Y. Detisch, et al.R. Brandão, A. Paulussen, M. Zeegers, M. Blok, E. Gómez García posted to prediction brca2 brca1 by merpublic on 2009-12-05 12:40:55 as
	Poly(ADP-ribose) polymerase-1 inhibitor treatment regresses autochthonous Brca2/p53-mutant mammary tumors in vivo and delays tumor relapse in combination with carboplatin. [My Copy] Cancer research, Vol. 69, No. 9. (1 May 2009), pp. 3850-3855. by Trevor Hay, James R. Matthews, Lucie Pietzka, et al.Alan Lau, Aaron Cranston, Anders O. Nygren, Anthony Douglas-Jones, Graeme C. Smith, Niall M. Martin, Mark O'Connor, Alan R. Clarke posted to parp brca2 by merpublic on 2009-12-03 19:51:47 as
	Selective Inhibition of BRCA2-Deficient Mammary Tumor Cell Growth by AZD2281 and Cisplatin [My Copy] In Clinical Cancer Research, Vol. 14, No. 12. (15 June 2008), pp. 3916-3925. by Bastiaan Evers, Rinske Drost, Eva Schut, et al.Michiel de Bruin, Eline van der Burg, Patrick W. B. Derksen, Henne Holstege, Xiaoling Liu, Ellen van Drunen, H. Berna Beverloo, Graeme C. M. Smith, Niall M. B. Martin, Alan Lau, Mark J. O'Connor, Jos Jonkers posted to brca2 by merpublic on 2009-12-03 19:42:23 as
	Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase [My Copy] Nature, Vol. 434, No. 7035. (14 April 2005), pp. 913-917. by Helen E. Bryant, Niklas Schultz, Huw D. Thomas, et al.Kayan M. Parker, Dan Flower, Elena Lopez, Suzanne Kyle, Mark Meuth, Nicola J. Curtin, Thomas Helleday posted to parp brca2 by merpublic on 2009-10-27 08:35:31 as
	Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy [My Copy] Nature, Vol. 434, No. 7035. (14 April 2005), pp. 917-921. by Hannah Farmer, Nuala McCabe, Christopher J. Lord, et al.Andrew N. J. Tutt, Damian A. Johnson, Tobias B. Richardson, Manuela Santarosa, Krystyna J. Dillon, Ian Hickson, Charlotte Knights, Niall M. B. Martin, Stephen P. Jackson, Graeme C. M. Smith, Alan Ashworth posted to parp brca2 brca1 by merpublic on 2009-10-27 08:32:25 as
	Resistance to therapy caused by intragenic deletion in BRCA2 [My Copy] Nature, Vol. 451, No. 7182. (28 February 2008), pp. 1111-1115. by Stacey L. Edwards, Rachel Brough, Christopher J. Lord, et al.Rachael Natrajan, Radost Vatcheva, Douglas A. Levine, Jeff Boyd, Jorge S. Reis-Filho, Alan Ashworth posted to parp brca2 by merpublic on 2009-10-27 07:58:21 as
	Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer [My Copy] Proceedings of the National Academy of Sciences, Vol. 104, No. 29. (2007), pp. 12117-12122. by Sven Rottenberg, Anders O. H. Nygren, Marina Pajic, et al.Fijs W. B. van Leeuwen, Ingrid van der Heijden, Koen van de Wetering, Xiaoling Liu, Karin E. de Visser, Kenneth G. Gilhuijs, Olaf van Tellingen, Jan P. Schouten, Jos Jonkers, Piet Borst posted to mouse_model chemosensitivity brca2 brca1 by merpublic on 2009-10-27 07:48:35 as
	Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers [My Copy] Breast Cancer Research, Vol. 11, No. 5. (2009), R76. by Susan Neuhausen, Sean Brummel, Yuan Ding, et al.Christian Singer, Georg Pfeiler, Henry Lynch, Katherine Nathanson, Timothy Rebbeck, Judy Garber, Fergus Couch, Jeffrey Weitzel, Steven Narod, Patricia Ganz, Mary Daly, Andrew Godwin, Claudine Isaacs, Olufunmilayo Olopade, Gail Tomlinson, Wendy Rubinstein, Nadine Tung, Joanne Blum, Daniel Gillen posted to modifiers brca2 brca1 by merpublic on 2009-10-22 18:40:40 as
	Mouse embryonic stem cell\|[ndash]\|based functional assay to evaluate mutations in BRCA2 [My Copy] Nature Medicine, Vol. 14, No. 8. (06 July 2008), pp. 875-881. by Sergey G. Kuznetsov, Pentao Liu, Shyam K. Sharan posted to vus brca2 by merpublic on 2009-10-19 16:19:35 as
	Platinum-based chemotherapy in triple-negative breast cancer [My Copy] Ann Oncol, Vol. 19, No. 11. (1 November 2008), pp. 1847-1852. by B. Sirohi, M. Arnedos, S. Popat, et al.S. Ashley, A. Nerurkar, G. Walsh, S. Johnston, I. E. Smith posted to tnbc platinum chemotherapy brca2 brca1 by merpublic on 2009-10-11 17:42:18 as
	Oral Contraceptives and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers [My Copy] J. Natl. Cancer Inst., Vol. 94, No. 23. (4 December 2002), pp. 1773-1779. by Steven A. Narod, Marie-Pierre Dube, Jan Klijn, et al.Jan Lubinski, Henry T. Lynch, Parviz Ghadirian, Diane Provencher, Ketil Heimdal, Pal Moller, Mark Robson, Kenneth Offit, Claudine Isaacs, Barbara Weber, Eitan Friedman, Ruth Gershoni-Baruch, Gad Rennert, Barbara Pasini, Theresa Wagner, Mary Daly, Judy E. Garber, Susan L. Neuhausen, Peter Ainsworth, Hakan Olsson, Gareth Evans, Michael Osborne, Fergus Couch, William D. Foulkes, Ellen Warner, Charmaine Kim-Sing, Olufunmilayo Olopade, Nadine Tung, Howard M. Saal, Jeffrey Weitzel, Sofia Merajver, Marion Gauthier-Villars, Helena Jernstrom, Ping Sun, Jean-Sebastien Brunet posted to modifiers brca2 brca1 by merpublic on 2009-10-08 19:28:48 as
	Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 23, No. 31. (1 November 2005), pp. 7804-7810. by Timothy R. Rebbeck, Tara Friebel, Theresa Wagner, et al.Henry T. Lynch, Judy E. Garber, Mary B. Daly, Claudine Isaacs, Olufunmilayo I. Olopade, Susan L. Neuhausen, Laura van 't Veer, Rosalind Eeles, D. Gareth Evans, Gail Tomlinson, Ellen Matloff, Steven A. Narod, Andrea Eisen, Susan Domchek, Katrina Armstrong, Barbara L. Weber, PROSE Study Group posted to oophorectomy modifiers brca2 brca1 by merpublic on 2009-10-08 14:15:04 as along with 1 person aeisen
	Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers. [My Copy] Journal of the National Cancer Institute, Vol. 100, No. 19. (1 October 2008), pp. 1361-1367. by Andrea Eisen, Jan Lubinski, Jacek Gronwald, et al.Pal Moller, Henry T. Lynch, Jan Klijn, Charmaine Kim-Sing, Susan L. Neuhausen, Lucy Gilbert, Parviz Ghadirian, Siranoush Manoukian, Gad Rennert, Eitan Friedman, Claudine Isaacs, Eliot Rosen, Barry Rosen, Mary Daly, Ping Sun, Steven A. Narod, Hereditary Breast Cancer Clinical Study Group posted to oophorectomy modifiers brca2 brca1 by merpublic on 2009-10-08 14:11:27 as along with 2 people and 2 groups aeisen songpku Roswell Cancer Crosstalk Breast Cancer Reading Club
	BRCA2 mutation carriers, reproductive factors and breast cancer risk [My Copy] Breast Cancer Res, Vol. 5, No. 5. (2003), pp. R121-R128. by Laufey Tryggvadottir, Elinborg Olafsdottir, Sigfridur Gudlaugsdottir, et al.Steinunn Thorlacius, Jon Jonasson, Hrafn Tulinius, Jorunn Eyfjord posted to modifiers brca2 brca1 by merpublic on 2009-10-08 13:58:43 as
	Smoking and risk of breast cancer in carriers of mutations in BRCA1 or BRCA2 aged less than 50 years [My Copy] Breast Cancer Research and Treatment, Vol. 109, No. 1. (1 May 2008), pp. 67-75. by Breast Cancer Family Registry, Kathleen Cuningham Consortium for Research into Familial Breast Cancer Australasia, Ontario Cancer Genetics Network Canada posted to modifiers brca2 brca1 by merpublic on 2009-10-07 22:58:38 as
	No Increased Risk of Breast Cancer Associated with Alcohol Consumption among Carriers of BRCA1 and BRCA2 Mutations Ages <50 Years [My Copy] Cancer Epidemiology Biomarkers & Prevention, Vol. 15, No. 8. (August 2006), pp. 1565-1567. by Valerie McGuire, Esther M. John, Anna Felberg, et al.Robert W. Haile, Norman F. Boyd, Duncan C. Thomas, Mark A. Jenkins, Roger L. Milne, Mary B. Daly, John Ward, Mary B. Terry, Irene L. Andrulis, Julia A. Knight, Andrew K. Godwin, Graham G. Giles, Melissa Southey, Dee W. West, John L. Hopper, Alice S. Whittemore posted to modifiers brca2 brca1 by merpublic on 2009-10-07 22:57:56 as
	Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update [My Copy] Breast Cancer Research and Treatment, Vol. 114, No. 1. (1 March 2009), pp. 127-135. by Ophira Ginsburg, Parviz Ghadirian, Jan Lubinski, et al.Cezary Cybulski, Henry Lynch, Susan Neuhausen, Charmaine Kim-Sing, Mark Robson, Susan Domchek, Claudine Isaacs, Jan Klijn, Susan Armel, William Foulkes, Nadine Tung, Pal Moller, Ping Sun, Steven Narod, Hereditary Breast Cancer Clinical Study Group posted to modifiers brca2 brca1 by merpublic on 2009-10-07 22:53:11 as
	Reproductive factors in hereditary breast cancer [My Copy] Breast Cancer Research and Treatment, Vol. 58, No. 3. (1 December 1999), pp. 293-299. by Helena C. B. Jernström, Oskar T. Johannsson, Niklas Loman, Åke Borg, Håkan Olsson posted to modifiers brca2 brca1 by merpublic on 2009-10-07 22:51:54 as
	Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland [My Copy] Breast Cancer Research and Treatment, Vol. 95, No. 2. (1 January 2006), pp. 105-109. by Jacek Gronwald, Tomasz Byrski, Tomasz Huzarski, et al.Cezary Cybulski, Ping Sun, Anna Tulman, Steven Narod, Jan Lubinski posted to modifiers brca2 brca1 by merpublic on 2009-10-07 22:48:44 as
	Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers [My Copy] Breast Cancer Research, Vol. 8, No. 2. (2006), R15. by Eitan Friedman, Joanne Kotsopoulos, Jan Lubinski, et al.Henry Lynch, Parviz Ghadirian, Susan Neuhausen, Claudine Isaacs, Barbara Weber, William Foulkes, Pal Moller, Barry Rosen, Charmaine K. Sing, Ruth G. Baruch, Peter Ainsworth, Mary Daly, Nadine Tung, Andrea Eisen, Olufunmilayo Olopade, Beth Karlan, Howard Saal, Judy Garber, Gad Rennert, Dawna Gilchrist, Charis Eng, Kenneth Offit, Michael Osborne, Ping Sun, Steven Narod, the Hereditary Breast Cancer Clinical Study Group posted to modifiers brca2 brca1 by merpublic on 2009-10-07 22:47:40 as
	Modifiers of risk of hereditary breast cancer [My Copy] Oncogene, Vol. 25, No. 43. (25 September 2006), pp. 5832-5836. by S. A. Narod posted to modifiers brca2 brca1 by merpublic on 2009-10-07 22:46:31 as
	Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2 [My Copy] Science, Vol. 302, No. 5645. (24 October 2003), pp. 643-646. by Mary-Claire King, Joan H. Marks, Jessica B. Mandell posted to penetrance modifiers brca2 brca1 by merpublic on 2009-10-07 22:42:32 as along with 1 person Zephyrus
	Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and P53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers [My Copy] Breast Cancer Research and Treatment, Vol. 116, No. 1. (1 July 2009), pp. 195-200. by Tair Kontorovich, Yoram Cohen, Uri Nir, Eitan Friedman posted to epigenetics brca2 brca1 by merpublic on 2009-10-07 22:38:59 as
	Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study [My Copy] The Lancet Oncology, Vol. 8, No. 1. (January 2007), pp. 26-34. by John R. McLaughlin, Harvey A. Risch, Jan Lubinski, et al.Pal Moller, Parviz Ghadirian, Henry Lynch, Beth Karlan, David Fishman, Barry Rosen, Susan L. Neuhausen posted to modifiers brca2 brca1 by merpublic on 2009-10-07 22:37:39 as
	Age at first birth and the risk of breast cancer in BRCA1 BRCA2 mutation carriers [My Copy] Breast Cancer Research and Treatment, Vol. 105, No. 2. (1 October 2007), pp. 221-228. by Joanne Kotsopoulos, Jan Lubinski, Henry Lynch, et al.Jan Klijn, Parviz Ghadirian, Susan Neuhausen, Charmaine Kim-Sing, William Foulkes, Pal Moller, Claudine Isaacs, Susan Domchek, Susan Randall, Kenneth Offit, Nadine Tung, Peter Ainsworth, Ruth Gershoni-Baruch, Andrea Eisen, Mary Daly, Beth Karlan, Howard Saal, Fergus Couch, Barbara Pasini, Teresa Wagner, Eitan Friedman, Gad Rennert, Charis Eng, Jeffrey Weitzel, Ping Sun, Steven Narod, The Hereditary Breast Cancer Clinical Study Group posted to modifiers brca2 brca1 by merpublic on 2009-10-07 22:36:11 as
	Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers [My Copy] Breast Cancer Research, Vol. 8, No. 6. (22 December 2006), R72. by Antonis Antoniou, Andrew Shenton, Eamonn Maher, et al.Emma Watson, Emma Woodward, Fiona Lalloo, Douglas Easton, D. Gareth Evans posted to modifiers brca2 brca1 by merpublic on 2009-10-07 22:35:14 as
	Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers [My Copy] Breast Cancer Research and Treatment by Roger Milne, Ana Osorio, Ramón, et al.Montserrat Baiget, Adriana Lasa, Eduardo Diaz-Rubio, Miguel de la Hoya, Trinidad Caldés, Alex Teulé, Conxi Lázaro, Ignacio Blanco, Judith Balmaña, Gessamí Sánchez-Ollé, Ana Vega, Ana Blanco, Isabel Chirivella, Eva Esteban Cardeñosa, Mercedes Durán, Eladio Velasco, Eduardo Martínez de Dueñas, María-Isabel Tejada, María-Dolores Miramar, María-Teresa Calvo, Carmen Guillén-Ponce, Raquel Salazar, Carlos San Román, Miguel Urioste, Javier Benítez posted to modifiers brca2 brca1 by merpublic on 2009-10-07 22:34:04 as
	Diet quality and BRCA -associated breast cancer risk [My Copy] Breast Cancer Research and Treatment, Vol. 103, No. 3. (1 July 2007), pp. 361-369. by A. Nkondjock, P. Ghadirian posted to modifiers brca2 brca1 by merpublic on 2009-10-07 20:26:39 as
	Oral Contraceptive Use and Risk of Early-Onset Breast Cancer in Carriers and Noncarriers of BRCA1 and BRCA2 Mutations [My Copy] Cancer Epidemiology Biomarkers & Prevention, Vol. 14, No. 2. (February 2005), pp. 350-356. by Roger L. Milne, Julia A. Knight, Esther M. John, et al.Gillian S. Dite, Ronald Balbuena, Argyrios Ziogas, Irene L. Andrulis, Dee W. West, Frederick P. Li, Melissa C. Southey, Graham G. Giles, Margaret R. E. McCredie, John L. Hopper, Alice S. Whittemore posted to modifiers brca2 brca1 by merpublic on 2009-10-07 20:17:53 as
	BRCA1 and BRCA2 Mutation Carriers, Oral Contraceptive Use, and Breast Cancer Before Age 50 [My Copy] Cancer Epidemiology Biomarkers & Prevention, Vol. 15, No. 10. (October 2006), pp. 1863-1870. by Robert W. Haile, Duncan C. Thomas, Valerie McGuire, et al.Anna Felberg, Esther M. John, Roger L. Milne, John L. Hopper, Mark A. Jenkins, A. Joan Levine, Mary M. Daly, Saundra S. Buys, Ruby T. Senie, Irene L. Andrulis, Julia A. Knight, Andrew K. Godwin, Melissa Southey, Margaret R. E. McCredie, Graham G. Giles, Lesley Andrews, Katherine Tucker, Alexander Miron, Carmel Apicella, Andrea Tesoriero, Anita Bane, Malcolm C. Pike, Alice S. Whittemore posted to modifiers brca2 brca1 by merpublic on 2009-10-07 20:16:12 as
	Oral Contraceptives and Breast Cancer Risk in the International BRCA1/2 Carrier Cohort Study: A Report From EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group [My Copy] J Clin Oncol, Vol. 25, No. 25. (1 September 2007), pp. 3831-3836. by Richard M. Brohet, David E. Goldgar, Douglas F. Easton, et al.Antonis C. Antoniou, Nadine Andrieu, Jenny Chang-Claude, Susan Peock, Rosalind A. Eeles, Margaret Cook, Carol Chu, Catherine Nogues, Christine Lasset, Pascaline Berthet, Hanne Meijers-Heijboer, Anne-Marie Gerdes, Hakan Olsson, Trinidad Caldes, Flora E. van Leeuwen, Matti A. Rookus posted to modifiers brca2 brca1 by merpublic on 2009-10-07 20:13:54 as
	Pregnancies, Breast-Feeding, and Breast Cancer Risk in the International BRCA1/2 Carrier Cohort Study (IBCCS) [My Copy] J. Natl. Cancer Inst., Vol. 98, No. 8. (19 April 2006), pp. 535-544. by Nadine Andrieu, David E. Goldgar, Douglas F. Easton, et al.Matti Rookus, Richard Brohet, Antonis C. Antoniou, Susan Peock, Gareth Evans, Diana Eccles, Fiona Douglas, E. Embrac, Catherine Nogues, Marion Gauthier-Villars, Agnes Chompret, O. Geneps, Flora E. Van Leeuwen, Irma Kluijt, N. Geo-Hebo, Javier Benitez, Brita Arver, Edith Olah, Ibccs C. Group, Jenny Chang-Claude posted to modifiers breast_cancer brca2 brca1 by merpublic on 2009-10-07 20:11:45 as
	Effect of Reproductive Factors and Oral Contraceptives on Breast Cancer Risk in BRCA1/2 Mutation Carriers and Noncarriers: Results from a Population-Based Study [My Copy] Cancer Epidemiology Biomarkers & Prevention, Vol. 17, No. 11. (November 2008), pp. 3170-3178. by Eunjung Lee, Huiyan Ma, Roberta McKean-Cowdin, et al.David Van Den Berg, Leslie Bernstein, Brian E. Henderson, Giske Ursin posted to modifiers breast_cancer brca2 brca1 by merpublic on 2009-10-07 19:51:23 as
	Breast-feeding and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers [My Copy] J. Natl. Cancer Inst., Vol. 96, No. 14. (21 July 2004), pp. 1094-1098. by H. Jernstrom, J. Lubinski, H. T. Lynch, et al.P. Ghadirian, S. Neuhausen, C. Isaacs, B. L. Weber, D. Horsman, B. Rosen, W. D. Foulkes, E. Friedman, R. Gershoni-Baruch, P. Ainsworth, M. Daly, J. Garber, H. Olsson, P. Sun, S. A. Narod posted to modifiers breast_cancer brca2 brca1 by merpublic on 2009-10-07 19:48:38 as
	Serous Tubal Intraepithelial Carcinoma: Its Potential Role in Primary Peritoneal Serous Carcinoma and Serous Cancer Prevention [My Copy] J Clin Oncol, Vol. 26, No. 25. (1 September 2008), pp. 4160-4165. by Joseph W. Carlson, Alexander Miron, Elke A. Jarboe, et al.Mana M. Parast, Michelle S. Hirsch, Yonghee Lee, Michael G. Muto, David Kindelberger, Christopher P. Crum posted to oophorectomy brca2 brca1 by merpublic on 2009-10-07 19:44:41 as
	Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study [My Copy] J Clin Oncol, Vol. 26, No. 8. (10 March 2008), pp. 1331-1337. by Noah D. Kauff, Susan M. Domchek, Tara M. Friebel, et al.Mark E. Robson, Johanna Lee, Judy E. Garber, Claudine Isaacs, D. Gareth Evans, Henry Lynch, Rosalind A. Eeles, Susan L. Neuhausen, Mary B. Daly, Ellen Matloff, Joanne L. Blum, Paul Sabbatini, Richard R. Barakat, Clifford Hudis, Larry Norton, Kenneth Offit, Timothy R. Rebbeck posted to oophorectomy brca2 brca1 by merpublic on 2009-10-07 19:42:52 as
	Risk-Reducing Salpingo-Oophorectomy in Patients With Germline Mutations in BRCA1 or BRCA2 [My Copy] J Clin Oncol, Vol. 25, No. 20. (10 July 2007), pp. 2921-2927. by Noah D. Kauff, Richard R. Barakat posted to oophorectomy brca2 brca1 by merpublic on 2009-10-07 19:41:50 as
	Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. [My Copy] Journal of the National Cancer Institute, Vol. 101, No. 2. (21 January 2009), pp. 80-87. by Timothy R. Rebbeck, Noah D. Kauff, Susan M. Domchek posted to oophorectomy modifiers brca2 brca1 by merpublic on 2009-10-07 19:40:39 as along with 1 person aeisen
	Skewed X Chromosome Inactivation and Breast and Ovarian Cancer Status: Evidence for X-Linked Modifiers of BRCA1 [My Copy] J. Natl. Cancer Inst., Vol. 100, No. 21. (5 November 2008), pp. 1519-1529. by Felicity Lose, David L. Duffy, Graham F. Kay, Australian O. Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Mary A. Kedda, Amanda B. Spurdle posted to modifiers brca2 brca1 by merpublic on 2009-10-07 19:37:37 as
	Phase II trial of the oral PARP inhibitor olaparib (AZD2281) in BRCA-deficient advanced ovarian cancer [My Copy] J Clin Oncol (Meeting Abstracts), Vol. 27, No. 15S. (20 May 2009), 5500. by M. W. Audeh, R. T. Penson, M. Friedlander, et al.B. Powell, K. M. Bell-McGuinn, C. Scott, J. N. Weitzel, J. Carmichael, A. Tutt posted to parp ovarian olaparib brca2 brca1 by merpublic on 2009-10-05 21:28:25 as
	Phase II trial of the oral PARP inhibitor olaparib in BRCA-deficient advanced breast cancer [My Copy] J Clin Oncol (Meeting Abstracts), Vol. 27, No. 18S. (20 June 2009), CRA501. by A. Tutt, M. Robson, J. E. Garber, et al.S. Domchek, M. W. Audeh, J. N. Weitzel, M. Friedlander, J. Carmichael posted to parp olaparib brca2 brca1 by merpublic on 2009-10-05 21:24:16 as
	Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes [My Copy] Breast Cancer Research, Vol. 11, No. 4. (09 July 2009), R47. by Olafur Stefansson, Jon Jonasson, Oskar Johannsson, et al.Kristrun Olafsdottir, Margret Steinarsdottir, Sigridur Valgeirsdottir, Jorunn Eyfjord posted to subtypes profiling brca2 brca1 by merpublic on 2009-10-05 16:36:55 as

Note: You may cite this page as: http://www.citeulike.org/user/merpublic/tag/brca2

Sort by:
Order:	Default Ascending Descending
Empty fields:	Default First Last

brca1	43
brca2	43
modifiers	26
genomics	22
parp	18
breast_cancer	10
gwas	8
methods	7
statistics	6
genetics	6
oophorectomy	6
review	5
dna_repair	5
tnbc	4
susceptibility	4
profiling	3
prediction	3
evolution	3
epigenetics	3
mouse_model	3
olaparib	3
chemotherapy	3
homologous_recombination	2
nhej	2
prostate	2
platinum	2
ds_repair	2
risk	2
forensic	2
lynch_syndrome	2
ovarian	2
ber	2
basal-like	1
population_genetics	1
outcome	1
biomarkers	1
pheochromocytoma	1
discovery	1
editorial	1
predisposition	1
onj	1
cnv	1
fun	1
ethics	1
subtypes	1
tamoxifen	1
cyp2d6	1
lung	1
sporadic	1
chordoma	1
somatic	1
chemosensitivity	1
vus	1
penetrance	1
ner	1

merpublic's brca2 [43 articles] Export Sort

merpublic's tags